Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from QT Imaging Holdings ( (QTI) ).
QT Imaging Holdings has released an investor presentation featuring supplemental product and operational information. This presentation highlights the company’s innovative imaging technology, which holds the potential to transform medical imaging. The company’s QT Scanner, a 3D imaging device, has received FDA clearance, which could enhance its market positioning and operational impact. The presentation also includes non-GAAP financial measures like EBITDA and Adjusted EBITDA, providing insights into the company’s financial trends and condition. This development could influence stakeholder decisions by offering a comprehensive overview of QT Imaging’s business prospects and performance metrics.
More about QT Imaging Holdings
QT Imaging Holdings is a medical device company specializing in imaging technology, particularly known for its QT Scanner, the only 3D imaging device that has received FDA clearance for use as a transmission and reflection ultrasonic imaging system for breast examination.
YTD Price Performance: -95.85%
Average Trading Volume: 140,608
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $10.48M
For an in-depth examination of QTI stock, go to TipRanks’ Stock Analysis page.
